Skip to main content

Table 1 Relationship between the expression of miRNAs and clinicopathological characteristics of colorectal cancer

From: Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer

GroupN = 80miR-4516miR-21-5p
Relative Expression Level
[M (P25, P75)]
PRelative Expression Level
[M (P25, P75)]
P
Age
 < 60432.09 (1.89, 2.25)0.09691.75 (1.54, 2.01)0.2768
 ≥ 60372.08 (1.95, 2.16)1.83 (1.65, 2.03)
Gender
 male382.14 (1.95, 2.24)0.85761.74 (1.55, 1.96)0.1522
 female422.11 (1.96, 2.27)1.84 (1.64, 2.04)
Tumor Size
 < 5 cm352.10 (1.96, 2.26)0.77741.74 (1.53, 1.94)0.4806
 ≥ 5 cm452.04 (1.95, 2.24)1.80 (1.62, 1.96)
Tumor Location
 colon382.12 (1.97, 2.29)0.51361.68 (1.53, 1.90)0.4000
 rectum422.15 (1.99, 2.22)1.78 (1.55, 1.96)
Infiltration Degree
 T1,T2301.94 (1.88, 1.98)0.04321.76 (1.59, 1.92)0.0758
 T3,T4502.17 (2.07, 2.26)1.79 (1.54, 1.94)
TNM Stage
 I-II442.40 (2.20,2.48)< 0.0012.04 (1.90,2.19)0.001
 III-IV361.79 (1.74, 1.92)1.58 (1.35, 1.64)
Lymph Node Metastasis
 non482.33 (2.14, 2.39)0.0022.04 (1.90,2.19)0.003
 exist321.80 (1.82, 1.90)1.58 (1.35, 1.64)
Distant Metastasis
 non522.37 (2.20, 2.42)0.0291.64 (1.50, 1.88)0.301
 exist281.81 (1.74, 1.89)1.77 (1.58, 1.96)
CEA Level (ng/ml)
 < 5412.09 (1.97, 2.20)0.4171.88 (1.68, 1.92)0.064
 ≥ 5392.12 (1.99, 2.24)1.60 (1.59, 1.79)